Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1130-1139. doi: 10.1164/rccm.201804-0621CI.

Abstract

Chronic obstructive pulmonary disease (COPD) is regarded as one of the leading causes of morbidity and mortality across the world, yet its proper diagnosis remains a challenge. Community-based population studies conducted in North and South America, Europe, Australia, and Asia have revealed that 10% to 12% of adults aged 40 years or older have evidence of persistent airflow limitation on spirometry, but only 20% to 30% of these subjects have been diagnosed with COPD. These studies collectively suggest that approximately 70% of COPD worldwide may be underdiagnosed. Conversely, other studies have shown that between 30% and 60% of patients with a previous physician diagnosis of COPD do not actually have the disease, and hence they have been overdiagnosed. In this review, we define under- and overdiagnosis and explore the prevalence and the burden of under- and overdiagnosis of COPD on both patients and healthcare systems. We further describe potential solutions to reduce the incidence of under- and overdiagnosis of COPD.

Keywords: chronic obstructive pulmonary disease; misdiagnosis; overdiagnosis; underdiagnosis.

Publication types

  • Review

MeSH terms

  • Asia
  • Australia
  • Diagnostic Errors / statistics & numerical data*
  • Europe
  • Humans
  • Internationality
  • Medical Overuse / statistics & numerical data*
  • North America
  • Pulmonary Disease, Chronic Obstructive / diagnosis*
  • South America
  • Spirometry